title: Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesis.
abstract: Group X secretory phospholipase A2 (GX sPLA2) hydrolyzes mammalian cell membranes, liberating free fatty acids and lysophospholipids. GX sPLA2 is produced as a pro-enzyme (pro-GX sPLA2) that contains an N-terminal 11-amino acid propeptide ending in a dibasic motif, suggesting cleavage by a furin-like proprotein convertase (PC). Although propeptide cleavage is clearly required for enzymatic activity, the protease(s) responsible for pro-GX sPLA2 activation have not been identified. We previously reported that GX sPLA2 negatively regulates adrenal glucocorticoid production, likely by suppressing liver X receptor-mediated activation of steroidogenic acute regulatory protein expression. In this study, using a FLAG epitope-tagged pro-GX sPLA2 expression construct (FLAG-pro-GX sPLA2), we determined that adrenocorticotropic hormone (ACTH) enhanced FLAG-pro-GX sPLA2 processing and phospholipase activity secreted by Y1 adrenal cells. ACTH increased the expression of furin and PCSK6, but not other members of the PC family, in Y1 cells. Overexpression of furin and PCSK6 in HEK 293 cells significantly enhanced FLAG-pro-GX sPLA2 processing, whereas siRNA-mediated knockdown of both PCs almost completely abolished FLAG-pro-GX sPLA2 processing in Y1 cells. Expression of either furin or PCSK6 enhanced the ability of GX sPLA2 to suppress liver X receptor reporter activity. The PC inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethyl ketone significantly suppressed FLAG-pro-GX sPLA2 processing and sPLA2 activity in Y1 cells, and it significantly attenuated GX sPLA2-dependent inhibition of steroidogenic acute regulatory protein expression and progesterone production. These findings provide strong evidence that pro-GX sPLA2 is a substrate for furin and PCSK6 proteolytic processing and define a novel mechanism for regulating corticosteroid production in adrenal cells.
authors.affiliation: From the Department of Pharmacology and Nutritional Sciences, Division of Nutritional Sciences, the Saha Cardiovascular Research Center, and.
authors.forename: Joseph D
authors.initials: JD
authors.lastname: Layne
authors.affiliation: the Department of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536.
authors.forename: Preetha
authors.initials: P
authors.lastname: Shridas
authors.affiliation: the Department of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536 nrwebb1@uky.edu.
authors.forename: Nancy R
authors.initials: NR
authors.lastname: Webb
mesh_terms: D000311:Adrenal Glands / Q000166:cytology / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001483:Base Sequence; D017931:DNA Primers; D004789:Enzyme Activation; D045683:Furin / Q000378:metabolism*; D051379:Mice; D054497:Phospholipases A2, Secretory / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D043484:Proprotein Convertases / Q000378:metabolism*; D059748:Proteolysis; D013256:Steroids / Q000096:biosynthesis*
chemical_list: D017931:DNA Primers; D013256:Steroids; D000324:Adrenocorticotropic Hormone; D054497:Phospholipases A2, Secretory; D043484:Proprotein Convertases; D045683:Furin
keywords: Adrenal; Glucocorticoid; Nuclear Receptor; Phospholipase; Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)